These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 22687788)

  • 1. A preliminary study of fluvoxamine maleate on depressive state and serum melatonin levels in patients after cerebral infarction.
    Sunami E; Usuda K; Nishiyama Y; Otori T; Katsura K; Katayama Y
    Intern Med; 2012; 51(10):1187-93. PubMed ID: 22687788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Post-stroke depression].
    Katayama Y; Usuda K; Nishiyama Y; Katsura K
    Nihon Ronen Igakkai Zasshi; 2003 Mar; 40(2):127-9. PubMed ID: 12708044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerability and safety of fluvoxamine and other antidepressants.
    Westenberg HG; Sandner C
    Int J Clin Pract; 2006 Apr; 60(4):482-91. PubMed ID: 16620364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of the efficacy and safety profiles between fluvoxamine and nortriptyline in Japanese patients with major depression.
    Otsubo T; Akimoto Y; Yamada H; Koda R; Aoyama H; Tanaka K; Mimura M; Nakagome K; Kamijima K
    Pharmacopsychiatry; 2005 Jan; 38(1):30-5. PubMed ID: 15706464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluvoxamine maleate in the treatment of depression: a single-center, double-blind, placebo-controlled comparison with imipramine in outpatients.
    Claghorn JL; Earl CQ; Walczak DD; Stoner KA; Wong LF; Kanter D; Houser VP
    J Clin Psychopharmacol; 1996 Apr; 16(2):113-20. PubMed ID: 8690826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluvoxamine but not citalopram increases serum melatonin in healthy subjects-- an indication that cytochrome P450 CYP1A2 and CYP2C19 hydroxylate melatonin.
    von Bahr C; Ursing C; Yasui N; Tybring G; Bertilsson L; Röjdmark S
    Eur J Clin Pharmacol; 2000 May; 56(2):123-7. PubMed ID: 10877005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma levels of catecholamine metabolites predict the response to sulpiride or fluvoxamine in major depression.
    Ueda N; Yoshimura R; Shinkai K; Nakamura J
    Pharmacopsychiatry; 2002 Sep; 35(5):175-81. PubMed ID: 12237788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minor depressive disorder and subsyndromal depressive symptoms: functional impairment and response to treatment.
    Rapaport MH; Judd LL
    J Affect Disord; 1998 Mar; 48(2-3):227-32. PubMed ID: 9543213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of fluvoxamine and fluoxetine in the treatment of major depression.
    Rapaport M; Coccaro E; Sheline Y; Perse T; Holland P; Fabre L; Bradford D
    J Clin Psychopharmacol; 1996 Oct; 16(5):373-8. PubMed ID: 8889909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of central poststroke pain with the selective serotonin reuptake inhibitor fluvoxamine.
    Shimodozono M; Kawahira K; Kamishita T; Ogata A; Tohgo S; Tanaka N
    Int J Neurosci; 2002 Oct; 112(10):1173-81. PubMed ID: 12587520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melatonin secretion during fluvoxamine treatment in medicated chronic schizophrenic patients: evidence for the development of tolerance to selective serotonin re-uptake inhibitor.
    Silver H; Barash I; Odnopozov N; Jahjah N; Mizruhin A
    Biol Psychiatry; 1996 Jul; 40(1):75-7. PubMed ID: 8780859
    [No Abstract]   [Full Text] [Related]  

  • 12. Fluvoxamine strongly inhibits melatonin metabolism in a patient with low-amplitude melatonin profile.
    Grözinger M; Härtter S; Wang X; Röschke J; Hiemke C; Rose DM
    Arch Gen Psychiatry; 2000 Aug; 57(8):812-3. PubMed ID: 10920471
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum beta-endorphin level in patients with depression on fluvoxamine.
    Djurović D; Milić-Askrabić J; Majkić-Singh N
    Farmaco; 1999 Mar; 54(3):130-3. PubMed ID: 10371024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pilot study: fluvoxamine treatment for depression and anxiety disorders in children and adolescents with cancer.
    Gothelf D; Rubinstein M; Shemesh E; Miller O; Farbstein I; Klein A; Weizman A; Apter A; Yaniv I
    J Am Acad Child Adolesc Psychiatry; 2005 Dec; 44(12):1258-62. PubMed ID: 16292117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible predictors of response to fluvoxamine for depression.
    Morishita S; Arita S
    Hum Psychopharmacol; 2003 Apr; 18(3):197-200. PubMed ID: 12672171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between clinical effects of fluvoxamine and the steady-state plasma concentrations of fluvoxamine and its major metabolite fluvoxamino acid in Japanese depressed patients.
    Gerstenberg G; Aoshima T; Fukasawa T; Yoshida K; Takahashi H; Higuchi H; Murata Y; Shimoyama R; Ohkubo T; Shimizu T; Otani K
    Psychopharmacology (Berl); 2003 Jun; 167(4):443-8. PubMed ID: 12682708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term treatment of psychotic (delusional) depression with fluvoxamine: an open pilot study.
    Zanardi R; Franchini L; Gasperini M; Smeraldi E; Perez J
    Int Clin Psychopharmacol; 1997 Jul; 12(4):195-7. PubMed ID: 9347379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of double-blind comparison of fluvoxamine and paroxetine in the treatment of depressed outpatients in menopause transition.
    Ushiroyama T; Ikeda A; Ueki M
    J Med; 2004; 35(1-6):151-62. PubMed ID: 18084873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Onset of clinical effects and plasma concentration of fluvoxamine in Japanese patients.
    Katoh Y; Uchida S; Kawai M; Takei N; Mori N; Kawakami J; Kagawa Y; Yamada S; Namiki N; Hashimoto H
    Biol Pharm Bull; 2010; 33(12):1999-2002. PubMed ID: 21139240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term combinational therapy of low-dose estrogen with selective serotonin re-uptake inhibitor (fluvoxamine) for oophorectomized women with hot flashes and depressive tendencies.
    Nagata H; Nozaki M; Nakano H
    J Obstet Gynaecol Res; 2005 Apr; 31(2):107-14. PubMed ID: 15771635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.